Home › Studies › PRJNA1305341
PRJNA1305341 SRP609471

Infant gut resistome in probiotic trial, Tanzania

ProRIDE Deep Seq Metagenomics Raw sequence reads

250 samples from infants in Tanzania, studying whether probiotic supplementation prevents colonisation by ARG-carrying pathogens and modulates the gut resistome and mobilome, in a randomized trial. machine-written summary

250 samples · 250 runs · TZ · Infant / toddler · 2026 · 41.54 Gbp / sample

Sources
✓Sequence archive 1,000○Abstract / description✓Full text 500✓Supplementary tables 988–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,000 sample values (collection date, country, subject id, timepoint)
○ Abstract / descriptionread; no usable statement
✓ Full text500 sample values (location site, preterm status) · PMC13198307
✓ Supplementary tables988 sample values (antibiotic exposure, diet, intervention, sex)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

RProbiotic (live microorganisms; single strain or mixture): 80 people · 126 samplesprobiotic 80 people · 126 samplesControl / pre-intervention baseline (sample level only): 72 people · 124 samplesno intervention 72 people · 124 samples
randomised to parallel arms

Probiotic (live microorganisms; single strain or mixture) design randomized_controlled_trial · population healthy_control · Oral bifidobacteria-based probiotic supplementation for first 4 weeks of life

“Oral probiotics during the first 4 weeks of life” — abstract:42013844 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
infant250
Sex
male129
female121
Country
TZ250
Body site
primary250
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 11 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 239 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 41.54 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

98 of 152 people sampled more than once (196 samples; median 2, up to 2 per person) · follow-up median 5 mo (max 5 mo) · median interval between samples 5 mo (time from timepoint labels).

A-1361A-1361: day 0A-1361: day 141A-1366A-1366: day 0A-1366: day 141A-1370A-1370: day 0A-1370: day 141A-1374A-1374: day 0A-1374: day 141A-1376A-1376: day 0A-1376: day 141A-1377A-1377: day 0A-1377: day 141A-1385A-1385: day 0A-1385: day 141A-1387A-1387: day 0A-1387: day 141A-1389A-1389: day 0A-1389: day 141A-1393A-1393: day 0A-1393: day 141A-1401A-1401: day 0A-1401: day 141A-1402A-1402: day 0A-1402: day 141A-1403A-1403: day 0A-1403: day 141A-1404A-1404: day 0A-1404: day 141A-1405A-1405: day 0A-1405: day 141A-1406A-1406: day 0A-1406: day 141A-1407A-1407: day 0A-1407: day 141A-1408A-1408: day 0A-1408: day 141A-1409A-1409: day 0A-1409: day 141A-1410A-1410: day 0A-1410: day 141A-1411A-1411: day 0A-1411: day 141A-1412A-1412: day 0A-1412: day 141A-1415A-1415: day 0A-1415: day 141A-1416A-1416: day 0A-1416: day 141A-1417A-1417: day 0A-1417: day 141A-1418A-1418: day 0A-1418: day 141A-1419A-1419: day 0A-1419: day 141A-1420A-1420: day 0A-1420: day 141A-1421A-1421: day 0A-1421: day 141A-1422A-1422: day 0A-1422: day 141A-1423A-1423: day 0A-1423: day 141A-1424A-1424: day 0A-1424: day 141A-1425A-1425: day 0A-1425: day 141A-1427A-1427: day 0A-1427: day 141A-1428A-1428: day 0A-1428: day 141A-1429A-1429: day 0A-1429: day 1410 d35 d2 mo3 mo5 mo

Each row is one person (36 shown of 98); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category250 100%
country250 100%250
health_condition0 0%
subject_id250 100%250
collection_date250 100%250
detailed_location250 100%
intervention250 100%250
location_site250 100%250
preterm_status250 100%250
sex250 100%250
timepoint_label250 100%250
diet246 98%246
antibiotic_exposure242 97%242
Papers (2)
  • Metabolic reprogramming of the infant gut by bifidobacteria-based probiotics drives exclusion of antibiotic-resistant pathobionts. PMID 42013844 PMC13198307 curated
  • Metabolic reprogramming of the infant gut by bifidobacteria-based probiotics drives exclusion of antibiotic-resistant pathobionts curated
Details
Archive description

To investigate whether probiotic supplementation can prevent colonisation by ARG-carrying pathogens and modulate the infant gut resistome and mobilome.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of infant / toddler by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage verdict include”
  • body site study.description · “modulate the infant gut resistome and mobilome.”
  • body site external_curation.infant_catalog · “infant triage verdict include (gut/stool scope)”
  • life stage external_curation.infant_catalog · “infant triage verdict include (0-3 y scope)”
  • life stage study.description · “and modulate the infant gut resistome and”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN50600567antibiotic_exposurenoR20.75paper.supp.mmc2.xlsx[Table_S2_Metadata!antibiotics]no
SAMN50600567collection_date2022-12-15R10.85biosample.attribute:collection_datecollection_date: 2022-12-15
SAMN50600567countryTZR10.90biosample_attrTanzania
SAMN50600567dietexclusive_breast_milkR20.75paper.supp.mmc2.xlsx[Table_S2_Metadata!exclusively_breastfed]yes
SAMN50600567interventionno_interventionR20.75paper.supp.mmc2.xlsx[Table_S2_Metadata!trial_arm]Control
SAMN50600567location_siteHaydom Lutheran HospitalR30.70paper.fulltext.methodsconducted at Haydom Lutheran Hospital (HLH) and the surrounding area
SAMN50600567preterm_statustermR30.80paper.fulltext.abstract152 full-term Tanzanian infants enrolled in the ProRIDE trial
SAMN50600567sexfemaleR20.75paper.supp.mmc2.xlsx[Table_S2_Metadata!sex]female
SAMN50600567subject_idA-1361R10.85biosample_attrA-1361
SAMN50600567timepoint_label6MR10.80biosample_attr6M
Sequencing

250 runs over 250 samples · mean 42.65 Gbp per run (median 41.54 Gbp, total 10,662.76 Gbp; 250 runs with a base count) · layout PAIRED 250 · platform DNBSEQ 250 · models DNBSEQ-T7 (250) · 0% of runs with a Sandpiper profile · first public 2026-03-22

Authors (10)

Bargheet A first · Bø GH · Hetland MAK · Justine M · Moyo SJ · Löhr IH · Blomberg B · Langeland N · Klingenberg C · Pettersen VK last

Downloads

PRJNA1305341.csv.gz (8.6 KB) · parquet (81.6 KB) — all 250 samples, every field with route and confidence · PRJNA1305341_determinations.csv.gz (12.7 KB) — 2,488 evidence rows

Samples (250 · every field this project has values for · hover a cell for its source)
Loading the sample table…